Naloxegol is a peripherally acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. As a pegylated derivative of the opioid… Read more
![Chemical structure of (4R,4aS,7R,7aR,12bS)-7-((2,5,8,11,14,17,20-Heptaoxadocosan-22-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F854601-71-1-4R4aS7R7aR12bS-7-25811141720-Heptaoxadocosan-22-yloxy-3-allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-3-Allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F20410-95-1-4R4aS7S7aR12bS-3-Allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a79-triol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-3-Allyl-7-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-3-Allyl-7-2-2-2-methoxyethoxyethoxyethoxy-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-3-Allyl-7-(2-(2-methoxyethoxy)ethoxy)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-3-Allyl-7-2-2-methoxyethoxyethoxy-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-4a,7-Bis((2,5,8,11,14,17,20-heptaoxadocosan-22-yl)oxy)-3-allyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-4a7-Bis25811141720-heptaoxadocosan-22-yloxy-3-allyl-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-9-ol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17,20,23-Octaoxapentacosan-25-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2125449-11-6-4R4aS7S7aR12bS-7-2581114172023-Octaoxapentacosan-25-yloxy-3-allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17,20-Heptaoxadocosan-22-yl)oxy)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2194602-13-4-4R4aS7S7aR12bS-7-25811141720-Heptaoxadocosan-22-yloxy-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17,20-Heptaoxadocosan-22-yl)oxy)-3-nitroso-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-7-25811141720-Heptaoxadocosan-22-yloxy-3-nitroso-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17-Hexaoxanonadecan-19-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2125449-09-2-4R4aS7S7aR12bS-7-258111417-Hexaoxanonadecan-19-yloxy-3-allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14-Pentaoxahexadecan-16-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-7-2581114-Pentaoxahexadecan-16-yloxy-3-allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11-Tetraoxatridecan-13-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7S7aR12bS-7-25811-Tetraoxatridecan-13-yloxy-3-allyl-12345677a-octahydro-4aH-412-methanobenzofuro32-eisoquinoline-4a9-diol.png&w=3840&q=75)


Naloxegol is a peripherally acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. As a pegylated derivative of the opioid antagonist naloxone, this medication requires rigorous evaluation throughout the pharmaceutical development lifecycle. Our collection of Naloxegol reference standards provides essential tools for this purpose, encompassing both pharmacopeial and non-pharmacopeial impurities, potential degradants, and relevant metabolites. These materials are critical for accurate impurity profiling and method validation, enabling laboratories to ensure consistent quality and safety. Furthermore, we offer stable isotope labelled compounds to serve as precise internal standards for mass spectrometry-based bioanalytical assays, supporting robust quantitative analysis in complex matrices.